Syringes and Needles Market in GCC Projected to Reach USD 1,164.90 Million by 2034, Growing at a 5.4% CAGR

GCC Syringes and Needles Market

The market for syringes and needles in the Gulf Cooperation Council (GCC) region is poised for significant growth, with sales expected to reach USD 688.5 million in 2024. The market is forecast to grow at a compound annual growth rate (CAGR) of 5.4%, ultimately reaching an estimated valuation of USD 1,164.9 million by 2034.

This growth is fueled by increasing healthcare requirements, advancements in medical treatments, and the growing adoption of syringes and needles in both hospitals and homecare settings. The rising demand for vaccinations, insulin delivery, and various injectable medications is further propelling the market expansion.

Key Insights – Highlights on the Emerging Opportunities in the GCC Syringe and Needle Industry

• GCC countries, specifically Saudi Arabia and the United Arab Emirates, are becoming popular travel destinations for medical tourists looking for high-quality medical care. Manufacturers of syringes and needles can boost revenues by providing top-notch medical equipment to clinics and hospitals that treat patients worldwide. This will help in broadening their global reach.
• Manufacturers can satisfy the particular demands of pediatric and geriatric patients by developing age-appropriate injectable devices with safety features, ergonomic designs, and possibilities for dose modification. This can address an unmet demand and improve patient satisfaction and compliance.
• The GCC region is witnessing a rise in biological medicines and the prevalence of chronic illnesses. This presents a potential for manufacturers to deliver specialty syringes and needles designed specifically for the administration of more complex pharmaceuticals.

Competitive Landscape

The syringe and needle industry in the GCC region is extremely competitive, with numerous established global businesses competing alongside regional players. Becton, Dickinson, and Company (BD) is an industry leader, relying on its large product range, robust distribution network, and sterling reputation to stay ahead.

Terumo Corporation, Smiths Medical, and Nipro Corporation constitute the top rivals contending for industry share, with each offering a varied selection of syringes and needles tailored to different medical specializations and uses.

Recent Developments

• In February 2023, Venus Remedies Ltd., a leading research-based pharmaceutical company, received a good manufacturing practices (GMP) certification from Saudi Arabia.
• In September 2022, BD (Becton, Dickinson, and Company), a renowned worldwide medical technology firm, launched a next-generation glass pre-fillable syringe (PFS) that sets a new benchmark for vaccine PFS performance, with new and tighter criteria for processability, cosmetics, contamination, and integrity.

Get the Comprehensive Full Report Now

Key Players in the Syringe and Needle Industry in GCC

• Becton, Dickinson and Company (BD)
• Terumo Corporation
• Smiths Medical
• Nipro Corporation
• B. Braun Melsungen AG
• Cardinal Health, Inc.
• Gerresheimer AG
• Hindustan Syringes & Medical Devices Ltd. (HMD)
• Medtronic plc
• Fresenius SE & Co. KGaA

Key Segments

By Product:

• Oral
• Hypodermic
  • Standard
  • Special Purpose
    • Insulin
    • Tuberculin
    • Other Special Purpose
    • Angiographic

By Usability:

• Disposable
• Reusable

By Material:

• Glass
• Polymer

By End User:

• Hospital
• Blood Collection Center
• Diabetic Care Center
• Veterinary Care Center
• Others

By Country:

• Kingdom of Saudi Arabia (KSA)
• United Arab Emirates (UAE)
• Qatar
• Bahrain
• Oman
• Kuwait

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube